Sernova Biotherapeutics (OTCMKTS:SEOVF) Stock Passes Below Fifty Day Moving Average – Time to Sell?

Shares of Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.10 and traded as low as $0.0779. Sernova Biotherapeutics shares last traded at $0.0779, with a volume of 31,360 shares traded.

Sernova Biotherapeutics Stock Performance

The firm has a fifty day moving average price of $0.10 and a 200 day moving average price of $0.11. The firm has a market capitalization of $30.06 million, a price-to-earnings ratio of -1.99 and a beta of 0.82.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last announced its quarterly earnings data on Thursday, June 11th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01).

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.